You are here: Industry Insights > Intranasal vaccine

News List

Lancaster University intranasal vaccine offers promise to block COVID-19 where it starts worldpharmanews
August 10, 2021
Research by Lancaster University scientists to create a COVID-19 vaccine which can be administered through the nose has taken a significant step forward.
Intranasal influenza vaccine produces strong immune response, Phase I study shows europeanpharmaceuticalreview
February 07, 2021
A Phase I clinical trial has shown that Ad4-H5-VTN, a single-dose, intranasal influenza vaccine, was safe and produced an immune response.
Bharat Biotech to begin trial of intranasal Covid-19 vaccine pharmaceutical-technology
December 10, 2020
Indian firm Bharat Biotech will be commencing Phase I trials of its intranasal Covid-19 vaccine candidate next month.
Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine pharmaceutical-business-review
November 12, 2020
Medigen Vaccine Biologics (MVC) has collaborated with BlueWillow Biologics for the development of intranasal vaccine for SARS-CoV-2, the novel coronavirus responsible for Covid-19 disease.
Ease of administration and dual protection can drive novel intranasal vaccine adoption: GlobalData expresspharma
November 11, 2020
Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months.
AuraVax Therapeutics partners with University of Houston for intranasal vaccine platform expresspharma
October 16, 2020
AuraVax Therapeutics announced it has entered into an exclusive license option agreement with the University of Houston with respect to the intellectual property covering a novel intranasal vaccine technology.
Intranasal vaccine made from peptide nanofibres shows efficacy in mice europeanpharmaceuticalreview
August 12, 2020
A new vaccine platform using self-assembling peptide nanofibres tagged with antigens has been tested successfully in mice, eliciting a strong immune response.